| Literature DB >> 21691469 |
Edward Durant1, Karl A Sporer.
Abstract
OBJECTIVE: This cross-sectional study describes the characteristics of patients with an abnormal Glasgow Coma Scale (GCS) in the prehospital setting.Entities:
Year: 2011 PMID: 21691469 PMCID: PMC3088371
Source DB: PubMed Journal: West J Emerg Med ISSN: 1936-900X
Figure.Cohort flow diagram.
GCS, Glasgow Coma Scale; AMS, altered mental status
Characteristics of patient by group.
| Mean age (years) | 61.4 ± 20.8 | 65.6 ± 21.5 |
| Sex (%) | ||
| Female | 55.1 | 49.0 |
| Male | 43.7 | 50.5 |
| Race (%) | ||
| White | 43.9 | 46.8 |
| Black/African America | 7.6 | 7.2 |
| Hispanic/Latino | 8.1 | 9.2 |
| Native American/Alaskan | <0.1 | 0 |
| Asian/Pacific Islander | 8.1 | 8.8 |
| Other/unknown | 32.3 | 28.0 |
| History (%) | ||
| Alcohol | 1.8 | 4.0 |
| Diabetes | 11.1 | 14.5 |
| Psychiatric | 3.5 | 3.5 |
| Seizure | 2.4 | 6.9 |
| Stroke/TIA | 3.4 | 6.6 |
| Substance use | 1.1 | 1.7 |
Indicates statistically significant result, (p<0.05)
GCS, Glasgow Coma Scale; TIA, transient ischemic attack
Percentage of patients by group receiving intervention
| IV access (%) | 61.7 | 75.7 |
| Medications administered (%) | 32.0 | 32.3 |
| Activated charcoal | 0.69 | 0.42 |
| Albuterol | 6.3 | 6.8 |
| Glucose, oral | 1.1 | 2.0 |
| Dextrose, IV | 0.8 | 9.0 |
| Glucagon | 0.03 | 1.2 |
| Midazolam | 0.17 | 2.4 |
| Naloxone | 0.18 | 5.3 |
| Nitroglycerin | 9.5 | 2.2 |
Indicates statistically significant result, (p<0.05)
GCS, Glasgow Coma Scale; IV, intravenous
Odds ratios and 95% confidence intervals for paramedic interventions by GCS group
| IV access | 1.57 (1.38–1.78) | 2.25 (1.85–2.73) | 3.60 (2.73–4.75) |
| Medications | 0.61 (0.53–0.70) | 1.27 (1.07–1.50) | 2.86 (2.34–3.49) |
All results were statistically significant (p<0.05)
GCS, Glasgow Coma Scale; IV, intravenous
Odds ratios and 95% confidence intervals for known altered mental status etiologies in past medical history
| Alcohol | 2.3 (1.75–3.00) | 2.60 (1.95–3.40) |
| Diabetes | 1.34 (1.17–1.54) | 1.25 (1.09–1.44) |
| Psychiatric | 1.00 (0.78–1.29) | 1.17 (0.91–1.52) |
| Seizures | 3.00 (2.40–3.80) | 2.50 (2.80–4.40) |
| Stroke/TIA | 2.00 (1.64–2.50) | 1.79 (1.45–2.20) |
| Substance use | 1.60 (1.09–2.30) | 1.86 (1.26–2.70) |
Indicates statistically significant result, (p<0.05)
TIA, transient ischemic attack
Unadjusted odds ratios and 95% confidence intervals for known altered level of consciousness etiologies in past medical history by Glasgow Coma Scale (GCS) category.
| Alcohol | 2.95 (2.18–4.00) | 2.01 (1.26–3.19) | 0.67 (0.27–1.66) |
| Diabetes | 1.01 (0.84–1.21) | 1.68 (1.35–2.10) | 2.04 (1.58–2.62) |
| Psychiatric | 1.24 (0.92–1.65) | 0.67 (0.39–1.13) | 0.74 (0.40–1.37) |
| Seizure | 3.44 (2.67–4.43) | 2.48 (1.71–3.59) | 2.50 (1.61–3.89) |
| Stroke/TIA | 1.84 (1.42–2.38) | 2.81 (2.07–3.81) | 1.45 (0.91–2.32) |
| Substance use | 1.82 (1.17–2.85) | 1.75 (0.95–3.25) | 0.66 (0.21–2.09) |
Indicates statistically significant result, (p<0.05)
TIA, transient ischemic attack
Age and sex adjusted odds ratios and 95% confidence intervals for known altered level of consciousness etiologies in past medical history by Glasgow Coma Scale (GCS) category.
| Alcohol | 3.11 (2.28–4.25) | 2.55 (1.59–4.08) | 0.80 (0.32–1.97) |
| Diabetes | 0.95 (0.79–1.14) | 1.53 (1.22–1.91) | 1.91 (1.48–2.45) |
| Psychiatric | 1.40 (1.04–1.89) | 0.84 (0.49–1.43) | 0.88 (0.47–1.63) |
| Seizure | 3.84 (2.96–4.97) | 3.10 (2.12–4.52) | 2.95 (1.89–4.61) |
| Stroke/TIA | 1.67 (1.28–2.18) | 2.40 (1.76–3.27) | 1.25 (0.78–2.01) |
| Substance use | 1.99 (1.27–3.13) | 2.30 (1.23–4.28) | 0.79 (0.25–2.53) |
Indicates statistically significant result, (p<0.05)
TIA, transient ischemic attack